A randomised, placebo controlled trial of prednisone in early Henoch Schonlein Purpura
Completed
- Conditions
- Henoch Schonlein PurpuraHaematological DisordersCoagulation defects, purpura and other haemorrhagic conditions
- Registration Number
- ISRCTN85109383
- Lead Sponsor
- Children's Hospital of Eastern Ontario Research Institute (CHEORI) (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Eligible participants were children between the ages of 2 and 15, presenting to the emergency room within 7 days of onset of Henoch Schonlein Purpura.
Children were excluded if:
1. Another explanation for purpura was present
2. They had a known underlying systemic vasculitis
3. They had been treated with any form of corticosteroids in the preceding month
4. They had a known chronic illness affecting the renal, gastrointestinal or immune systems
5. They had an active infection
6. They were experiencing a life-threatening complication of Henoch Schonlein Purpura
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method